CELLARIUM

THE KOREA REGENERATIVE MEDICINE GUIDE

GuidesClinics & HospitalsDoctorsPlan Your VisitSearchCompare Clinics
← Back to The Treatment Library

Cell manufacturing

Cell identity and purity

Knowing what is in the product is different from knowing whether it helps patients.

“Use this guide to frame clear, indication-specific questions for your specialist consultation.”

PATIENT EVIDENCE & CONSULTATION GUIDE

Category: Cell manufacturing · Editorial Review: Updated 20 October 2026 · 3 minute read

Identity asks what the product is

Identity testing is intended to confirm that the preparation has the characteristics expected for that product. Depending on the product, this may involve molecular features, cell markers, or other measurements. The goal is to distinguish the intended material from something else. A label such as regenerative cells is not an identity specification because it does not define a particular preparation.

Purity asks what else is present

A cell preparation can contain unwanted cell populations or residual materials from manufacturing. The relevant impurities depend on the process and intended use. Purity does not necessarily mean that every product must contain only one cell type; some are intentionally mixed. What matters is whether the mixture is defined, controlled, and appropriate for its intended clinical evaluation.

Quality and benefit are separate

A product may meet its identity and purity specifications while still having uncertain clinical effectiveness. Conversely, a promising research result does not excuse inadequate product characterization. Patients need both a credible quality process and relevant outcome evidence. Neither a certificate nor a scientific publication alone provides a complete assessment of the proposed treatment.

How to ask without technical jargon

Ask the team to explain how it confirms the right material is being administered and what unwanted components it checks for. Request a plain-language account of the release decision. If a product fails a check, there should be a clear process for withholding it. The question is not whether the clinic can display technical terms, but whether those terms describe a controlled product.

Continue exploring

  • Culture-expanded cells
  • Cell count, viability, and dose
  • Potency: biological activity versus marketing strength
  • Prepare your consultation checklist

Sources & further reading

  • FDA — Quality Cell and Gene Therapy Products
  • ISSCR — Guide to Stem Cell Treatments

Read alongside your treating specialist’s advice. Clinical eligibility, exact products and treatment plans require individual assessment.

CONTINUE YOUR PREPARATION

Prepare for your clinical conversation.

Combine the questions in this guide with our 12-point consultation checklist or explore Seoul clinic profiles.

Consultation ChecklistExplore Clinics & HospitalsAll 147 Guides

CELLARIUM

Knowledge before possibility.

Cellarium is an independent editorial guide to regenerative medicine and stem cell consultations in South Korea. It does not provide medical advice, diagnosis, or treatment, and is not affiliated with any clinic or hospital.

EDITORIAL DIRECTORY

The Treatment Library (147 Guides)Clinics & Hospitals in SeoulMeet the DoctorsSide-by-Side Clinic ComparisonConsultation Checklist & PlanningEditorial ApproachPrivacy & Site Information

© 2026 Cellarium — The Korea Regenerative Medicine Guide. Educational reference only; always consult a qualified specialist.